Skip to main content

Episodic Ataxias

  • Chapter
  • First Online:
Paroxysmal Movement Disorders

Abstract

Episodic ataxias (EA) are rare autosomal dominant channelopathies characterized by recurrent episodes of ataxia, vertigo and incoordination. So far, eight subtypes have been described with identified gene mutations in five of them (EA1, EA2, EA5, EA6 and EA8). Clinical clues, for example precipitating triggers, duration of attacks, associated interictal signs and treatment response, can aid the distinction of the different subtypes of EA. The current chapter will give an overview of clinical symptoms, genetic background and treatment for the different subtypes of EA. It will also briefly discuss the clinico-genetic characteristics of further disorders that may present with recurring bouts of paroxysmal ataxia and may, therefore, fall within the episodic ataxia spectrum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 69.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15(3):369–91.

    Article  Google Scholar 

  2. Klockgether T, Paulson H. Milestones in ataxia. Mov Disord. 2011;26(6):1134–41.

    Article  Google Scholar 

  3. Guterman EL, Yurgionas B, Nelson AB. Pearls & Oy-sters: episodic ataxia type 2: case report and review of the literature. Neurology. 2016;86(23):e239–41.

    Article  Google Scholar 

  4. VanDyke DH, Griggs RC, Murphy MJ, Goldstein MN. Hereditary myokymia and periodic ataxia. J Neurol Sci. 1975;25(1):109–18.

    Article  CAS  Google Scholar 

  5. Graves TD, Cha YH, Hahn AF, Barohn R, Salajegheh MK, Griggs RC, et al. Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation. Brain. 2014;137(Pt 4):1009–18.

    Article  Google Scholar 

  6. Tomlinson SE, Rajakulendran S, Tan SV, Graves TD, Bamiou DE, Labrum RW, et al. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. J Neurol Neurosurg Psychiatry. 2013;84(10):1107–12.

    Article  Google Scholar 

  7. Rajakulendran S, Schorge S, Kullmann DM, Hanna MG. Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics. 2007;4(2):258–66.

    Article  CAS  Google Scholar 

  8. Romaniello R, Zucca C, Tonelli A, Bonato S, Baschirotto C, Zanotta N, et al. A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J Neurol Neurosurg Psychiatry. 2010;81(8):840–3.

    Article  Google Scholar 

  9. Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology. 2004;62(1):17–22.

    Article  CAS  Google Scholar 

  10. Molloy A, Kimmich O, Martindale J, Moore H, Hutchinson M, O’Riordan S. A novel CACNA1A mutation associated with adult-onset, paroxysmal head tremor. Mov Disord. 2013;28(6):842–3.

    Article  Google Scholar 

  11. Vighetto A, Froment JC, Trillet M, Aimard G. Magnetic resonance imaging in familial paroxysmal ataxia. Arch Neurol. 1988;45(5):547–9.

    Article  CAS  Google Scholar 

  12. Lee H, Jang DH, Jang JH, Kim T. Effectiveness of levetiracetam in an acetazolamide-unresponsive patient with episodic ataxia type 2 by a novel CACNA1A nonsense mutation. Eur J Neurol. 2017;24(7):e43–e4.

    Article  CAS  Google Scholar 

  13. Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011;77(3):269–75.

    Article  CAS  Google Scholar 

  14. Sintas C, Carreno O, Fernandez-Castillo N, Corominas R, Vila-Pueyo M, Toma C, et al. Mutation spectrum in the CACNA1A gene in 49 patients with episodic ataxia. Sci Rep. 2017;7(1):2514.

    Article  Google Scholar 

  15. Pradotto L, Mencarelli M, Bigoni M, Milesi A, Di Blasio A, Mauro A. Episodic ataxia and SCA6 within the same family due to the D302N CACNA1A gene mutation. J Neurol Sci. 2016;371:81–4.

    Article  CAS  Google Scholar 

  16. Cader MZ, Steckley JL, Dyment DA, McLachlan RS, Ebers GC. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology. 2005;65(1):156–8.

    Article  CAS  Google Scholar 

  17. Steckley JL, Ebers GC, Cader MZ, McLachlan RS. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology. 2001;57(8):1499–502.

    Article  CAS  Google Scholar 

  18. Farmer TW, Mustian VM. Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations. Arch Neurol. 1963;8:471–80.

    Article  CAS  Google Scholar 

  19. Damji KF, Allingham RR, Pollock SC, Small K, Lewis KE, Stajich JM, et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol. 1996;53(4):338–44.

    Article  CAS  Google Scholar 

  20. Merrill MJ, Nai D, Ghosh P, Edwards NA, Hallett M, Ray-Chaudhury A. Neuropathology in a case of episodic ataxia type 4. Neuropathol Appl Neurobiol. 2016;42(3):296–300.

    Article  CAS  Google Scholar 

  21. Escayg A, De Waard M, Lee DD, Bichet D, Wolf P, Mayer T, et al. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet. 2000;66(5):1531–9.

    Article  CAS  Google Scholar 

  22. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology. 2005;65(4):529–34.

    Article  CAS  Google Scholar 

  23. de Vries B, Mamsa H, Stam AH, Wan J, Bakker SL, Vanmolkot KR, et al. Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake. Arch Neurol. 2009;66(1):97–101.

    Article  Google Scholar 

  24. Choi KD, Jen JC, Choi SY, Shin JH, Kim HS, Kim HJ, et al. Late-onset episodic ataxia associated with SLC1A3 mutation. J Hum Genet. 2017;62(3):443–6.

    Article  CAS  Google Scholar 

  25. Iwama K, Iwata A, Shiina M, Mitsuhashi S, Miyatake S, Takata A, et al. A novel mutation in SLC1A3 causes episodic ataxia. J Hum Genet. 2018;63(2):207–11.

    Article  CAS  Google Scholar 

  26. Kerber KA, Jen JC, Lee H, Nelson SF, Baloh RW. A new episodic ataxia syndrome with linkage to chromosome 19q13. Arch Neurol. 2007;64(5):749–52.

    Article  Google Scholar 

  27. Conroy J, McGettigan P, Murphy R, Webb D, Murphy SM, McCoy B, et al. A novel locus for episodic ataxia:UBR4 the likely candidate. Eur J Hum Genet. 2014;22(4):505–10.

    Article  CAS  Google Scholar 

  28. Sweney MT, Newcomb TM, Swoboda KJ. The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism, CAPOS and beyond. Pediatr Neurol. 2015;52(1):56–64.

    Article  Google Scholar 

  29. Demos MK, van Karnebeek CD, Ross CJ, Adam S, Shen Y, Zhan SH, et al. A novel recurrent mutation in ATP1A3 causes CAPOS syndrome. Orphanet J Rare Dis. 2014;9:15.

    Article  Google Scholar 

  30. Chang IJ, Adam MP, Jayadev S, Bird TD, Natarajan N, Glass IA. Novel pregnancy-triggered episodes of CAPOS syndrome. Am J Med Genet A. 2018;176(1):235–40.

    Article  CAS  Google Scholar 

  31. Stagnaro M, Pisciotta L, Gherzi M, Di Rocco M, Gurrieri F, Parrini E, et al. ATP1A3 spectrum disorders: a video-documented history of 7 genetically confirmed early onset cases. Eur J Paediatr Neurol. 2018;22(2):264–71.

    Article  Google Scholar 

  32. Ebrahimi-Fakhari D, Saffari A, Westenberger A, Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015;138(Pt 12):3476–95.

    Article  Google Scholar 

  33. Gardiner AR, Bhatia KP, Stamelou M, Dale RC, Kurian MA, Schneider SA, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology. 2012;79(21):2115–21.

    Article  CAS  Google Scholar 

  34. Dmitry Tchapyjnikov, Mohamad A. Mikati, Acetazolamide-responsive Episodic Ataxia Without Baseline Deficits or Seizures Secondary to GLUT1 Deficiency. The Neurologist. 23(1):17–18.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christos Ganos .

Editor information

Editors and Affiliations

Electronic Supplementary Material

Characteristic interictal myokymia in a patient with genetically confirmed EA1 (MOV 10757 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zittel, S., Ganos, C. (2021). Episodic Ataxias. In: Sethi, K.D., Erro, R., Bhatia, K.P. (eds) Paroxysmal Movement Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-53721-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-53721-0_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-53720-3

  • Online ISBN: 978-3-030-53721-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics